Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for urinary tract infection
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
Urinarytractinfections in children Urinarytractinfections in children - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search Urinarytractinfections in children Last reviewed: February 2019 Last updated: October 2018 Summary A common diagnosis among infants and children; if missed, can lead to renal scarring, hypertension, and end-stage renal disease. Non-specific signs and symptoms may herald UTI, and practitioners (...) in the absence of urinary reflux. Definition Paediatric urinarytractinfection (UTI) is defined as a common bacterial infection involving the lower urinarytract (cystitis), the upper urinarytract (pyelonephritis), or both, causing illness in children. Recognising and treating these infections promptly and accurately is important. UTI is associated with pyelonephritis, which has potential sequelae, including renal scarring. Untreated UTI can also lead to hypertension and end-stage renal disease
with fever suggests pyelonephritis. Diagnosed using urine dipstick, microscopic urinalysis (bacteria, white blood cell, red blood cell), and urine culture. Antibiotic selection should be guided by local bacterial susceptibilities and guidelines, or based on known urine culture and sensitivity. Definition A urinarytractinfection (UTI) is an infection of the kidneys, bladder, or urethra. Infectious cystitis is the most common type of UTI, which is caused by a bacterial infection of the bladder (...) Urinarytractinfections in women Urinarytractinfections in women - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search Urinarytractinfections in women Last reviewed: February 2019 Last updated: January 2019 Summary Can be clinically categorised into uncomplicated/complicated, acute, or recurrent. Escherichia coli is the most common organism in uncomplicated infections. Costovertebral angle tenderness together
Urinarytractinfections in men Urinarytractinfections in men - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search Urinarytractinfections in men Last reviewed: February 2019 Last updated: September 2018 Summary Rarely occurs before 50 years of age. Often associated with abnormal structure or function of the urinarytract (complicated UTI). Catheter-associated UTI is the most common cause of nosocomial infection (...) . Imaging of the urinarytract is recommended for men with persistent haematuria, voiding dysfunction without a clearly identifiable cause such as benign prostatic hyperplasia (BPH), failure of initial therapy, or signs of upper tractinfection. Should generally be treated with a fluoroquinolone antibiotic for 7 to 14 days. Asymptomatic bacteriuria does not require treatment except before urological procedures. Definition Urinarytractinfection (UTI) is an inflammatory reaction of the urinarytract
Xanthogranulomatous pyelonephritis with reno-colic fistula: A rare complication of urinarytractinfectionUrinarytractinfection (UTI) is one of the most common presentations in general practice and, in most instances, occurs in a single episode and is easily treated with a course of anti-microbial therapy. In the case of recurrent urinarytractinfections, it is important to consider evaluation for any underlying causes. We report the case of a 32 year old female who had recurrent UTIs
Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent UrinaryTractInfection and Radiation Induced Cystitis 1 Public Summary Document Application No. 1439 – Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for painful bladder syndrome /interstitial cystitis and recurrent urinarytractinfection and radiation induced cystitis Applicant: Juno (...) syndrome (PBS)/interstitial cystitis (IC), patients with recurrent urinarytractinfections (rUTIs) and patients with radiation-induced cystitis, was received by the Department of Health from Juno Pharmaceuticals Pty Ltd. 2. MSAC’s advice to the Minister MSAC agreed that painful bladder syndrome/interstitial cystitis (PBS/IC), recurrent urinarytractinfections (rUTIs) and radiation induced cystitis (RIC) can be debilitating conditions and there is a place for instillation of sodium hyaluronate
Symptomatic treatment of uncomplicated lower urinarytractinfections in the ambulatory setting: randomised, double blind trial. Objective To investigate whether symptomatic treatment with non-steroidal anti-inflammatory drugs (NSAIDs) is non-inferior to antibiotics in the treatment of uncomplicated lower urinarytractinfection (UTI) in women, thus offering an opportunity to reduce antibiotic use in ambulatory care.Design Randomised, double blind, non-inferiority trial.Setting 17 general
Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinarytractinfection Enterococcus faecalis is a leading causative agent of catheter-associated urinarytractinfection (CAUTI), the most common hospital-acquired infection. Its ability to grow and form catheter biofilm is dependent upon host fibrinogen (Fg). Examined here are how bacterial and host proteases interact with Fg and contribute to virulence. Analysis
UrinaryTractInfection. Urinarytractinfections (UTIs) are common in both inpatient and outpatient settings. This article provides an evidence-based, clinically relevant overview of management of UTIs, including screening, diagnosis, treatment, and prevention. Conditions covered include acute cystitis (both uncomplicated and complicated), catheter-associated UTI, and asymptomatic bacteriuria in both women and men.
Meropenem and vaborbactam (Vabomere) - To treat adults with complicated urinarytractinfections VABOMERE (meropenem and vaborbactam) Powder for Injection U.S. Department of Health and Human Services Search FDA Submit search VABOMERE (meropenem and vaborbactam) Powder for Injection VABOMERE Company: Rempex Pharmaceuticals, Inc. Application No.: 209776 Approval Date: 08/29/2017 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF
Elevated antibiotic resistance of Sudanese urinarytractinfection bacteria This study determined the prevalence of urinarytractinfections in the Sudanese state of Khartoum and antimicrobial susceptibility pattern of isolated bacterial species. 200 adult patient urine specimens were collected and cultivated to identify the growing bacteria and their susceptibility to antibiotics. 35 % of specimens had significant bacterial growth. The most frequent isolates in this study were E. coli, E
A 5-day antibiotic course for treatment of intermittent catheter-associated urinarytractinfection in patients with spinal cord injury This was a retrospective monocentric study conducted at Centre Calvé, France, with the objective of evaluating the effectiveness of a 5-day course of antibiotics for symptomatic (mild urinarytractinfection, UTI) or asymptomatic (aBact) bacteriuria in patients with spinal cord injury on intermittent catheterization.This study was conducted from May 2013
Recurrent UrinaryTractInfection No. 250-Recurrent UrinaryTractInfection - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 39, Issue 10, Pages e422–e431 No. 250-Recurrent UrinaryTractInfection x Annette Epp , MD (Principal Author) Saskatoon, SK x Annick Larochelle , MD (Principal Author) St. Lambert, QC No. 250 (Reaffirmed October 2017) DOI: To view the full text, please login as a subscribed user or . Click (...) to view the full text on ScienceDirect. Abstract Objective To provide an update of the definition, epidemiology, clinical presentation, investigation, treatment, and prevention of recurrent urinarytractinfections in women. Options Continuous antibiotic prophylaxis, post-coital antibiotic prophylaxis, and acute self-treatment are all efficient alternatives to prevent recurrent urinarytractinfection. Vaginal estrogen and cranberry juice can also be effective prophylaxis alternatives. Evidence
Plazomicin (Zemdri) - To treat adults with complicated urinarytractinfections Drug Approval Package: ZEMDRI (plazomicin) U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: ZEMDRI (plazomicin) Company: Achaogen, Inc. Application Number: 210303 Orig 1 Approval Date: 07/27/2018 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. FDA Approval Letter and Labeling (PDF) (PDF) FDA Application Review